Wow, that is a very significant change. The original plan was to "line up" the "final data date" on both trials to approximately July 1.

This is a material change in strategy. NP had been talking about the 50 patient "interim report" for quite some time, and seemed to have confirmed that it was happening with 51 patients (last one injected in late May).

Oh well......Nader time, Nader strategy. We are all just observers (and owners).